Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Neurotone develops auditory training software for hearing loss patients. The platform helps patients improve hearing comprehension through brain-based learning, built on over 20 years of clinical research in hearing care.
0 investors
Neuroview Technology develops a small implantable subcutaneous device for long-term EEG brain monitoring, transmitting neurological data to the cloud via a patient's smartphone for review by clinicians. The platform applies AI/ML data analytics to EEG data to improve diagnosis and management of epilepsy and other neurologic disorders.
0 investors
NeuroVision develops diagnostic tools and a telehealth care-delivery platform for earlier detection and longitudinal monitoring of neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Its products include the BrainHealth Clinic cognitive care telehealth platform, Afina AI-based retinal imaging, and the Duritect diagnostics platform, connecting biomarker testing and teleneurology access with clinical workflows.
0 investors
Neuxtec develops iNMS, a neuromuscular stimulation technology that accelerates muscle recovery and enhances athletic performance by optimizing muscle fiber recruitment and reducing soreness after training or physical activity.
0 investors
New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
0 investors
NexGel manufactures FDA-registered and ISO-certified hydrogel patch technology for over-the-counter medications, wound care, cosmetics, and commercial applications. The platform supports integration of active ingredients and is marketed for its versatility and consumer experience.
0 investors
Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
0 investors
NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.
0 investors
Northwest Medical Isotopes (NWMI) is designing, licensing, and building a radioisotope production facility to process low-enriched uranium targets and produce fission-based Molybdenum-99 (Mo-99), the parent isotope for Tc-99m used in nuclear medicine imaging. It aims to supply a domestic and worldwide source of pharmaceutical-grade Mo-99 to radiopharmacies and medical imaging centers, with its production facility planned in Columbia, Missouri.
0 investors
Noveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
0 investors
Nuclein makes the DASH Rapid PCR System, a compact point-of-care diagnostic instrument that delivers lab-quality PCR test results in about 15 minutes from a single cartridge. It is used in clinics such as urgent care, pediatric, and primary care settings to test for multiple viruses during a patient visit.
0 investors
Nuo Therapeutics is a commercial-stage medical device company developing biodynamic therapies for wound care. Its flagship product, Aurix, is a hematogel that uses a patient's own platelets and plasma to promote healing.
0 investors
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
0 investors
NVMedtech develops the TUBE flow diverter, a minimally invasive implant that treats brain aneurysms by promoting rapid aneurysm occlusion and tissue growth across the aneurysm neck. The device is a medical implant for neurovascular intervention, offering high surface coverage, high pore density, and a heparin surface coating.
0 investors
NV Therapeutics develops non-viral gene therapies designed to be safe, effective, and scalable. The company targets a new generation of genetic treatments for disease.
0 investors
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
0 investors
NXT Biomedical is a medical device incubator that develops and spins out startups building clinical medical technologies aimed at addressing unmet needs and reducing healthcare costs. It plans to invest $25 million over five years to create five to eight companies.
0 investors
Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.
0 investors
OcuDyne develops an investigational ophthalmic device called OPTiC that is currently undergoing clinical trials in the United States. The company operates in the medical device and healthcare sector, focused on eye care applications.
0 investors
Ocugenix is a biotechnology company developing ophthalmology therapeutics based on NIH-funded research into the molecular mechanisms of wound healing and cellular response, originating from a research team at the University of Pittsburgh Medical Center. Its focus areas include eye diseases such as glaucoma and retinal conditions.
0 investors
A radiation oncology center offering proton therapy for cancer patients of all ages and diagnoses, with a clinical team of physicians and supporting staff. It participates in national clinical trials as part of its cancer treatment services.
0 investors
Okogen is a clinical-stage ophthalmic pharmaceutical company developing a treatment for acute infectious conjunctivitis, covering both bacterial and viral forms. Its lead product is in clinical trials as a single treatment for all forms of the condition.
0 investors
Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
0 investors
Omega Ophthalmics develops the Gemini Capsule, an implantable device that maintains the capsular bag in an open configuration after cataract removal and provides a stable position for intraocular lens implantation. The product is used in ophthalmic surgery.
0 investors